CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Pre-Tax Margin

Income before tax as a percentage of revenue.

CeriBell, Inc.NASDAQ: CBLL

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -74.5%

Pre-tax margin was -74.5% in Q1 FY2026, down 12.1 pp from a year earlier. On a trailing-twelve-month basis it was -63.5%, down 0.9 pp year over year. Over 3 fiscal years it widened by 83.4 pp.

Context

  • Pre-tax margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-74.5%-19.9 pp QoQ
Last fiscal yearDec 2025
-60.0%+1.8 pp YoY
LTMMar 2026
-63.5%-0.9 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-12.1 pp——
1 year+1.8 pp——
3 years+83.4 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-60.0%
Year-over-year change
+1.8pp

Pre-Tax Margin vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 pre-tax margin of -63.5% is the 6th highest of the 7 companies compared; the peer median is -23.1%.
  • Its year-over-year change of -0.9 pp is the lowest of 7, against a peer median of +8.0 pp.
  • Over three fiscal years its change of +83.4 pp compares with a peer median of +72.3 pp.
CBLL Competitors Peer median
Pre-Tax Margin for CBLL and competitors
Company Period LTM level YoY 3-year change
BWAYBrainsWay Ltd.LTM Mar 202615.8% +5.5 pp+62.7 pp
LIVNLivaNova PLCLTM Sep 20267.9% +22.2 pp-8.5 pp
NPCENeuroPace, Inc.LTM Mar 2026-21.7% +7.8 pp+82.0 pp
STIMNeuronetics, Inc.LTM Mar 2026-24.6% +29.8 pp+30.9 pp
ECORelectroCore, Inc.LTM Mar 2026-44.9% +1.5 pp+219.4 pp
CBLLCeriBell, Inc.LTM Mar 2026-63.5% -0.9 pp+83.4 pp
CVRXCVRx, Inc.LTM Mar 2026-89.2% +8.3 pp+89.8 pp
Peer median (excluding CBLL) -23.1%+8.0 pp+72.3 pp

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.92M45.23M65.44M89.06M
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.9%84.4%86.7%87.9%
Research & Development7.24M9M13.56M19.14M
Selling, General & Admin50.27M59.21M82.9M117.53M
Operating Expenses57.51M68.2M96.46M136.68M
Depreciation & Amortization497K847K1.14M1.34M
EBITDA(35.06M)(26.51M)(37.32M)(50.18M)
EBITDA Margin-135.3%-58.6%-57.0%-56.3%
Operating Income(36.02M)(30.04M)(39.71M)(58.4M)
Operating Margin-139.0%-66.4%-60.7%-65.6%
Interest Income0000
Interest Expense1.6M2.1M1.99M1.89M
Other Income / Expenses(1.14M)588K(746K)4.99M
Income Before Tax(37.16M)(29.45M)(40.46M)(53.41M)
Pre-Tax Margin-143.4%-65.1%-61.8%-60.0%
Income Tax Expense2K11K00
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Net Margin-143.4%-65.1%-61.8%-60.0%
EPS (Basic)(1.59)(1.26)(3.39)(1.46)
EPS (Diluted)(1.59)(1.26)(3.39)(1.46)
Weighted Avg Shares23.32M23.32M11.95M36.54M
Weighted Avg Shares (Diluted)23.32M23.32M11.95M36.54M

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.